CD151 and ovarian carcinoma: Recent evidences have recorded that CD151 frequently overexpresses in malignant tumor tissues, including hepatocellular carcinoma (HCC) 2, gallbladder carcinoma 3, breast cancer 4 and ovarian cancer 5, and acts as a “driver” in tumor progression through formation of tetraspanin CD151-enriched microdomains 2.